Soligenix Inc (SNGX)

$1.58 -0.02 (-1.25%)
Market Cap 6.77M
Revenue (ttm) 120,000.00
Net Income (ttm) -8.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,891.67%
Debt to Equity Ratio 0.00
Volume 638,500
Avg Vol 5,266,766
Day's Range N/A - N/A
Shares Out 4.29M
Stochastic %K 28%
Beta 1.95
Analysts Strong Buy
Price Target $17.50

Company Profile

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 538 8200
Fax: 609 452 6467
Address:
29 Emmons Drive, Suite B-10, Princeton, United States
Nick_clap
Nick_clap Oct. 26 at 6:47 PM
$SNGX bit quiet on here
0 · Reply
UnicornProfits
UnicornProfits Oct. 24 at 8:33 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $ACHR $VERI $KULR $SNGX --!
1 · Reply
SR_JACK
SR_JACK Oct. 23 at 12:35 PM
🚨 $SNGX read what i said or watch and learn! 👇 Smart traders got in with me early! 🟢💣🔥
0 · Reply
diagio
diagio Oct. 23 at 12:19 PM
$LASE $GXAI $PPCB $SNGX Coming to piss away what few pennies he has left on $YYAI 😂😂😂
0 · Reply
diagio
diagio Oct. 22 at 8:28 PM
$YYAI Where you been loser? It's been a while since you checked in. Had to get a 9-5 to make up your losses? 😂 $GXAI $PPCB $SNGX $XPON
0 · Reply
student56
student56 Oct. 22 at 2:27 PM
$SNGX HOLD
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 21 at 7:33 PM
Researchers Develop Nanoparticles That Could Combat Scarring, Inflammation in ARLD $SNGX https://ibn.fm/aWIeC #biomedstocks #Nanoparticles
0 · Reply
RIPJAWx
RIPJAWx Oct. 20 at 4:55 PM
$SNGX BIG NEWS INCOMING! 🚀🚀🚀
0 · Reply
student56
student56 Oct. 20 at 6:31 AM
$SNGX overnight price is 1.74$ WOW
0 · Reply
Anonymous10000
Anonymous10000 Oct. 19 at 8:55 PM
$SNGX you'll want to watch $SLS on Monday. Big gain after hours Friday is just the start of the run. Company meeting on Oct. 29 with news!
0 · Reply
Latest News on SNGX
Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

Oct 14, 2025, 7:30 AM EDT - 13 days ago

Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Oct 7, 2025, 7:30 AM EDT - 20 days ago

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Sep 30, 2025, 7:30 AM EDT - 27 days ago

Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix Announces Closing of $7.5 Million Public Offering

Sep 29, 2025, 4:05 PM EDT - 27 days ago

Soligenix Announces Closing of $7.5 Million Public Offering

Soligenix Announces Pricing of $7.5 Million Public Offering

Sep 26, 2025, 6:33 AM EDT - 4 weeks ago

Soligenix Announces Pricing of $7.5 Million Public Offering

Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor

Sep 23, 2025, 7:30 AM EDT - 4 weeks ago

Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

Sep 4, 2025, 7:30 AM EDT - 7 weeks ago

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 7:30 AM EDT - 7 weeks ago

Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Why Is Soligenix Stock Soaring On Monday?

Aug 18, 2025, 1:03 PM EDT - 2 months ago

Why Is Soligenix Stock Soaring On Monday?

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

Aug 18, 2025, 7:30 AM EDT - 2 months ago

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results

Aug 14, 2025, 7:30 AM EDT - 2 months ago

Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results

NetworkNewsAudio Announces Audio Press Release (APR) on Promising First-Line Therapy for Rare Skin Cancer

Aug 8, 2025, 8:30 AM EDT - 2 months ago

NetworkNewsAudio Announces Audio Press Release (APR) on Promising First-Line Therapy for Rare Skin Cancer

Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet's Disease

Jul 31, 2025, 7:30 AM EDT - 3 months ago

Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet's Disease

Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones

Jul 8, 2025, 7:30 AM EDT - 3 months ago

Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones

Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions

Jul 1, 2025, 7:30 AM EDT - 4 months ago

Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions

Soligenix Highlights Dr. Ellen Kim's Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials

Jun 6, 2025, 9:37 AM EDT - 5 months ago

Soligenix Highlights Dr. Ellen Kim's Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials

Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results

May 9, 2025, 7:30 AM EDT - 6 months ago

Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results

Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks

Apr 14, 2025, 7:30 AM EDT - 7 months ago

Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks

IBN Initiates Coverage of Soligenix Inc.

Mar 25, 2025, 8:30 AM EDT - 7 months ago

IBN Initiates Coverage of Soligenix Inc.

Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants

Mar 25, 2025, 7:30 AM EDT - 7 months ago

Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants

Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results

Mar 21, 2025, 7:30 AM EDT - 7 months ago

Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results

HyBryte™ Treatment Studies Presented at Two Medical Conferences in March

Mar 6, 2025, 7:30 AM EST - 8 months ago

HyBryte™ Treatment Studies Presented at Two Medical Conferences in March

Soligenix to Present at BIO CEO & Investor Conference

Feb 4, 2025, 7:30 AM EST - 9 months ago

Soligenix to Present at BIO CEO & Investor Conference

Soligenix to Present at Upcoming Investor Conferences

Jan 16, 2025, 7:30 AM EST - 10 months ago

Soligenix to Present at Upcoming Investor Conferences

HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Jan 14, 2025, 7:30 AM EST - 10 months ago

HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Dec 16, 2024, 7:30 AM EST - 11 months ago

Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment

Dec 2, 2024, 7:30 AM EST - 11 months ago

HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Nov 19, 2024, 7:30 AM EST - 1 year ago

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix to Present at November 21st Virtual Investor Summit Microcap Event

Nov 15, 2024, 7:30 AM EST - 1 year ago

Soligenix to Present at November 21st Virtual Investor Summit Microcap Event

Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease

Nov 14, 2024, 7:15 AM EST - 1 year ago

Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results

Nov 8, 2024, 7:30 AM EST - 1 year ago

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin

Oct 22, 2024, 7:30 AM EDT - 1 year ago

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin

Soligenix Invited to Present at Upcoming Investor Conferences

Oct 16, 2024, 7:30 AM EDT - 1 year ago

Soligenix Invited to Present at Upcoming Investor Conferences

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference

Oct 7, 2024, 7:30 AM EDT - 1 year ago

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference

Soligenix Announces Partnership with Sterling Pharma Solutions

Oct 3, 2024, 7:30 AM EDT - 1 year ago

Soligenix Announces Partnership with Sterling Pharma Solutions

Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Sep 20, 2024, 9:00 AM EDT - 1 year ago

Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Aug 16, 2024, 9:00 AM EDT - 1 year ago

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

AREC

Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results

Aug 9, 2024, 7:30 AM EDT - 1 year ago

Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

Jul 15, 2024, 10:16 AM EDT - 1 year ago

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

Soligenix stock rallies 400% on positive HyBryte trial results

Jul 9, 2024, 12:46 PM EDT - 1 year ago

Soligenix stock rallies 400% on positive HyBryte trial results

Crude Oil Down 1%; Soligenix Shares Surge

Jul 9, 2024, 12:11 PM EDT - 1 year ago

Crude Oil Down 1%; Soligenix Shares Surge

Nano-Cap Soligenix Stock Surges Over 200% On Tuesday, Here's Why

Jul 9, 2024, 11:38 AM EDT - 1 year ago

Nano-Cap Soligenix Stock Surges Over 200% On Tuesday, Here's Why

Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Jul 9, 2024, 7:30 AM EDT - 1 year ago

Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma

Jun 25, 2024, 7:30 AM EDT - 1 year ago

Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

Jun 14, 2024, 7:30 AM EDT - 1 year ago

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jun 7, 2024, 9:00 AM EDT - 1 year ago

Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

STSS

Soligenix Announces Reverse Stock Split

May 31, 2024, 7:30 AM EDT - 1 year ago

Soligenix Announces Reverse Stock Split

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

May 29, 2024, 7:30 AM EDT - 1 year ago

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

Nick_clap
Nick_clap Oct. 26 at 6:47 PM
$SNGX bit quiet on here
0 · Reply
UnicornProfits
UnicornProfits Oct. 24 at 8:33 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $ACHR $VERI $KULR $SNGX --!
1 · Reply
SR_JACK
SR_JACK Oct. 23 at 12:35 PM
🚨 $SNGX read what i said or watch and learn! 👇 Smart traders got in with me early! 🟢💣🔥
0 · Reply
diagio
diagio Oct. 23 at 12:19 PM
$LASE $GXAI $PPCB $SNGX Coming to piss away what few pennies he has left on $YYAI 😂😂😂
0 · Reply
diagio
diagio Oct. 22 at 8:28 PM
$YYAI Where you been loser? It's been a while since you checked in. Had to get a 9-5 to make up your losses? 😂 $GXAI $PPCB $SNGX $XPON
0 · Reply
student56
student56 Oct. 22 at 2:27 PM
$SNGX HOLD
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 21 at 7:33 PM
Researchers Develop Nanoparticles That Could Combat Scarring, Inflammation in ARLD $SNGX https://ibn.fm/aWIeC #biomedstocks #Nanoparticles
0 · Reply
RIPJAWx
RIPJAWx Oct. 20 at 4:55 PM
$SNGX BIG NEWS INCOMING! 🚀🚀🚀
0 · Reply
student56
student56 Oct. 20 at 6:31 AM
$SNGX overnight price is 1.74$ WOW
0 · Reply
Anonymous10000
Anonymous10000 Oct. 19 at 8:55 PM
$SNGX you'll want to watch $SLS on Monday. Big gain after hours Friday is just the start of the run. Company meeting on Oct. 29 with news!
0 · Reply
RIPJAWx
RIPJAWx Oct. 17 at 7:19 PM
$SNGX WHATS THE NEWS?
0 · Reply
student56
student56 Oct. 17 at 1:42 PM
$SNGX holding 333 shares
0 · Reply
jnicoles1
jnicoles1 Oct. 15 at 8:51 PM
$SNGX what is happening with this any idea ?
0 · Reply
nightstocker15
nightstocker15 Oct. 15 at 12:53 PM
$CAPS looking nice this morning from after hours drop! Also watching $SNGX to make a move higher 💪 👀
0 · Reply
Josh43
Josh43 Oct. 15 at 12:06 PM
$SNGX holding just 1500 shares now Also 6000 shares Apvo and 1000 shares of mltx. May add more shares again
0 · Reply
Love_To_Learn
Love_To_Learn Oct. 15 at 10:44 AM
$SNGX using your 1.68 and $PRZO 1.73 for stock that will b popping soonish multibagger blending grids
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 14 at 6:22 PM
BioMedNewsBreaks — $SNGX Updates U.S. Medical Advisory Board to Advance Phase 3 Development of HyBryte for CTCL https://ibn.fm/6ET3I
0 · Reply
mike537
mike537 Oct. 14 at 12:11 PM
$SNGX https://ir.soligenix.com/2025-10-14-Soligenix-Updates-United-States-Medical-Advisory-Board-for-Cutaneous-T-Cell-Lymphoma
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 13 at 6:25 PM
$SNGX Closes Multimillion-Dollar Public Offering to Fund Pipeline Through 2026 https://ibn.fm/2CZsY
0 · Reply
CalculatedSwing
CalculatedSwing Oct. 13 at 5:07 PM
$VTAK 🔥 post-meeting glow-up: Proposals sailed through, paving way for epic financings & growth! 128% Q2 rev surge, Croatia tender win, LockeT EU domination, + USPTO patent blitz. Med degen alert: $SNGX $PBM $HSDT $SINT – rare disease rockets & neuro breakthroughs incoming! Strap in for liftoff! 🧬📈 #BiotechBulls #DegenMed
1 · Reply
StockChiefs
StockChiefs Oct. 12 at 9:44 PM
Incase you guys missed the 900% GLTO run (1.2 mil float), Make sure add MTEX to your squeeze wathclists! Very nice after hours breakout - good momentum. Only 600k shares float. Holding some shares for a pre-market continuation run MTEX recently ran +100% in After-Hours and now it is breaking out again ! Keep it on watch bulls! $ACXP $PALI $RYDE $SNGX Clean setups
0 · Reply
HopehelpsU
HopehelpsU Oct. 12 at 12:26 PM
$SNGX I sold 1.70s last week, paid 1.13.... Looking for a re-entry 👀..... Would love to buy back starting around 1.50....I think 1.40 could provide exceptional support. GL....
0 · Reply